---
id: srinivasan-2023
slug: pmc-10116133
title: Benefit of enteral baclofen in cerebral palsy
pmcid: PMC10116133
year: 2023
type: review
journal: Journal of Pediatric Rehabilitation Medicine
authors: [Srinivasan R]
author_short: Srinivasan
tags: [spasticity, baclofen, treatment]
---

<div className="research-note-header" data-tier="mid">
ðŸ“Š Review
</div>

# Benefit of enteral baclofen in the management of spasticity in cerebral palsy

[PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC10116133/)

## Key Findings

> "Although oral baclofen is not as effective for cerebral spasticity as it is for spinal spasticity, it remains commonly prescribed"

> "Side effect profile is manageable and easy to troubleshoot"

### Mechanism
- GABAB receptor agonist
- Reduces muscle spasticity
- Improves range of motion

### Clinical Benefits
- Decreases spasms
- Improves positioning
- Reduces pain
- Enhances caregiving ease
- Supports better brace fitting
- Prevents contracture formation

### Side Effects
- Drowsiness (most common) - manage by bedtime dosing
- Constipation - manage with laxatives
- Tolerance: occurs in 3-20% of cases
- "Baclofen holidays" of 3-37 days can restore effectiveness
